Qiagen N.V.

  • WKN: A2DKCH
  • ISIN: NL0012169213
  • Land: The Netherlands

Nachricht vom 29.04.2022 | 12:24

QIAGEN N.V.: Release of a capital market information

QIAGEN N.V. / Form 6-K for the quarterly period ended March 31, 2022
QIAGEN N.V.: Release of a capital market information
29.04.2022 / 12:24
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

QIAGEN N.V. hereby announces that the FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2022, was filed with the UNITED STATES SECURITIES AND EXCHANGE COMMISSION (SEC).

The document is now available on the website of QIAGEN:
https://s28.q4cdn.com/125951340/files/doc_financials/2022/q1/2022-Q1-6-K-final-as-filed-April-28-2022.pdf

 



29.04.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Events im Fokus

Termine 2022

1./2. Juni 2022: Fachkonferenz Immobilien & Software | IT

13./14. Juli 2022: Fachkonferenz Beteiligungsgesellschaften & Consumer/Leisure

12./13. Oktober 2022: Fachkonferenz Finanzdienstleistungen/Technologie

News im Fokus

Deutsche Post AG: Bekanntgabe gemäß Art. 5 Abs. 1 der Verordnung (EU) Nr. 596/2014 i.V.m. Art. 2 Abs. 1 der Del. VO (EU) 2016/1052 der Kommission (in der jeweils gültigen Fassung)

28. Juni 2022, 11:00

Aktueller Webcast

Kinarus Therapeutics Holding AG

Replay KOL Webcast: Christian Pruente on wAMD and KIN001

27. Juni 2022

Aktuelle Research-Studie

EAMD European AeroMarine Drones AG

Original-Research: EAMD European AeroMarine Drones AG (von GBC AG): BUY

29. Juni 2022